Northeast Financial Consultants Inc Neoleukin Therapeutics, Inc. Transaction History

Northeast Financial Consultants Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 13, 2020	SELL	$6.12 - $13.64 $91,800 - $204,600	-15,000 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$2.65 - $12.72 $62,010 - $297,648	-23,400 Reduced 60.94%	15,000 $185,000
Q3 2019 Nov 13, 2019	BUY	$2.33 - $3.76 $89,472 - $144,384	38,400 New	38,400 $108,000

199K

Ticker NLTX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 42,579,900
Description
Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of vario...

Get notified when there are updates to the investment portfolio of Northeast Financial Consultants Inc, based on Form 13F filings with the SEC.

Stay updated on Northeast Financial Consultants Inc with notifications on news.